Andrea Iannone’s recent spat with Aprilia teammate Aleix Espargaro is only the latest episode in a catalogue of controversy that has dogged the one-time MotoGP winner in recent times. Regardless of the outcome of his drugs test, Aprilia stands to lose more than it gains by keeping him
Andrea Iannone’s career exists in limbo as he continues to await the outcome of his WADA doping infringement trial, which follows a urine sample taken during last year’s Malaysian MotoGP round that tested positive for an anabolic steroid.
Provisionally suspended by the FIM, the Aprilia rider has been forced to miss the two pre-season tests at Sepang and in Qatar, while his participation in the opening race of the year next month is also in serious doubt as he waits for the results of a hair sample (an apparently more accurate way of testing for banned substances) he submitted in the wake of his failed urine samples.
To continue reading subscribe to Join prime and take advantage of member benefits:
- Custom news feed based on your favorite series
- Ad-free environment
- Access to the Giorgio Piola archive
- Best of F1 Racing
- Higher resolution photos
Unlock the benefits of PRIME and enjoy the full range of features offered by your favorite motorsport news site.
Subscribe to Motorsport.com PRIME
Already have an account? Sign in